Xiamen Amoytop Biotech Co Ltd (688278) — Cash Flow Quality Index
Xiamen Amoytop Biotech Co Ltd (688278) has a Cash Flow Quality Index of 1.99x as of September 2023. Operating cash flow of CN¥332.29 Million exceeds net income of CN¥166.73 Million, indicating high earnings quality where cash backs reported profits. Explore Xiamen Amoytop Biotech Co Ltd (688278) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xiamen Amoytop Biotech Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Xiamen Amoytop Biotech Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688278 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Xiamen Amoytop Biotech Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Xiamen Amoytop Biotech Co Ltd. For live market cap and the full company financial profile, see 688278 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.52x | CN¥430.63 Million | CN¥827.60 Million | ▼ -43.6% |
| 2023 | 0.92x | CN¥512.10 Million | CN¥555.45 Million | ▼ -27.1% |
| 2022 | 1.27x | CN¥363.16 Million | CN¥287.02 Million | ▼ -2.3% |
| 2021 | 1.30x | CN¥234.78 Million | CN¥181.26 Million | ▲ +62.7% |
| 2020 | 0.80x | CN¥92.61 Million | CN¥116.35 Million | ▼ -58.5% |
| 2019 | 1.92x | CN¥123.30 Million | CN¥64.29 Million | ▼ -65.6% |
| 2018 | 5.57x | CN¥89.15 Million | CN¥16.00 Million | ▲ +352.4% |
| 2017 | -2.21x | CN¥-11.41 Million | CN¥5.17 Million | ▼ -252.5% |
| 2016 | 1.45x | CN¥42.43 Million | CN¥29.31 Million | — |